213 related articles for article (PubMed ID: 27435953)
21. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
22. Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Addobbati C; de Azevêdo Silva J; Tavares NA; Monticielo O; Xavier RM; Brenol JC; Crovella S; Chies JA; Sandrin-Garcia P
Ann Hum Genet; 2016 Jan; 80(1):1-6. PubMed ID: 26464189
[TBL] [Abstract][Full Text] [Related]
23. Association of MTMR3 rs12537 at miR-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in Egyptian patients.
Senousy MA; Helmy HS; Fathy N; Shaker OG; Ayeldeen GM
Sci Rep; 2019 Aug; 9(1):12299. PubMed ID: 31444373
[TBL] [Abstract][Full Text] [Related]
24. Interferon III-related IL28RA variant is associated with rheumatoid arthritis and systemic lupus erythematosus and specific disease sub-phenotypes.
Drehmer MN; Castro GV; Pereira IA; de Souza IR; Löfgren SE
Int J Rheum Dis; 2021 Jan; 24(1):49-55. PubMed ID: 33269531
[TBL] [Abstract][Full Text] [Related]
25. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
[TBL] [Abstract][Full Text] [Related]
26. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
Kim T; Bae SC; Kang C
Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
[TBL] [Abstract][Full Text] [Related]
27. Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.
Solus JF; Chung CP; Oeser A; Li C; Rho YH; Bradley KM; Kawai VK; Smith JR; Stein CM
Clin Rheumatol; 2015 Aug; 34(8):1375-82. PubMed ID: 25652333
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y
Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240
[TBL] [Abstract][Full Text] [Related]
29. ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico.
Ramírez-Bello J; Sun C; Valencia-Pacheco G; Singh B; Barbosa-Cobos RE; Saavedra MA; López-Villanueva RF; Nath SK
PLoS One; 2019; 14(11):e0224543. PubMed ID: 31774828
[TBL] [Abstract][Full Text] [Related]
30. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
31. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans.
Choi CB; Kang CP; Seong SS; Bae SC; Kang C
Arthritis Rheum; 2006 Dec; 54(12):3838-41. PubMed ID: 17133581
[TBL] [Abstract][Full Text] [Related]
32. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus.
Sánchez E; Orozco G; López-Nevot MA; Jiménez-Alonso J; Martín J
Tissue Antigens; 2004 Jan; 63(1):54-7. PubMed ID: 14651524
[TBL] [Abstract][Full Text] [Related]
34. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis.
Huang Q; Chen SS; Li J; Tao SS; Wang M; Leng RX; Pan HF; Ye DQ
Ir J Med Sci; 2018 Feb; 187(1):243-249. PubMed ID: 28560518
[TBL] [Abstract][Full Text] [Related]
35. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.
Lin SC; Yen JH; Tsai JJ; Tsai WC; Ou TT; Liu HW; Chen CJ
Arthritis Rheum; 2004 Mar; 50(3):770-5. PubMed ID: 15022318
[TBL] [Abstract][Full Text] [Related]
36. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
[TBL] [Abstract][Full Text] [Related]
37. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
38. Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility.
do Canto LM; Farias TD; Medeiros MD; Coêlho CC; Sereia AF; de Carlos Back LK; de Mello FM; Zimmermann AF; Pereira IA; de Souza IR
Rev Bras Reumatol Engl Ed; 2016; 56(6):483-489. PubMed ID: 27914594
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
40. Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.
Van Damme KFA; Hertens P; Martens A; Gilis E; Priem D; Bruggeman I; Fossoul A; Declercq J; Aegerter H; Wullaert A; Hochepied T; Hoste E; Vande Walle L; Lamkanfi M; Savvides SN; Elewaut D; Lambrecht BN; van Loo G
Sci Rep; 2023 Oct; 13(1):17992. PubMed ID: 37865713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
